The company is in liquidation (20/06/2024)
Imcyse is a biotechnology company founded in 2010 by Professor Saint-Remy (spin-off of the KU Leuven [Catholic University of Leuven). It develops innovative curative therapies in the field of chronic inflammatory and autoimmune diseases and allergic pathologies.
